Ameriprise Financial Inc Alector, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Alector, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 176,209 shares of ALEC stock, worth $327,748. This represents 0.0% of its overall portfolio holdings.

Number of Shares

176,209

Previous 103,106 70.9%

Holding current value

$327,748

Previous $468,000 75.64%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.34 - $6.58 $317,267 - $481,017	73,103 Added 70.9%	176,209 $822,000
Q2 2024 Aug 14, 2024	BUY	$4.19 - $6.23 $4,311 - $6,410	1,029 Added 1.01%	103,106 $468,000
Q1 2024 May 15, 2024	SELL	$5.69 - $8.08 $30,464 - $43,260	-5,354 Reduced 4.98%	102,077 $614,000
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $103,135 - $229,525	27,357 Added 34.16%	107,431 $857,000
Q3 2023 Nov 14, 2023	SELL	$5.2 - $8.77 $473,470 - $798,526	-91,052 Reduced 53.21%	80,074 $518,000
Q2 2023 Aug 14, 2023	SELL	$5.86 - $7.93 $295,285 - $399,592	-50,390 Reduced 22.75%	171,126 $1.03 Million
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $192,529 - $323,844	32,911 Added 17.45%	221,516 $1.37 Million
Q4 2022 Feb 14, 2023	SELL	$6.88 - $9.55 $11,902 - $16,521	-1,730 Reduced 0.91%	188,605 $1.74 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $989,368 - $1.59 Million	120,802 Added 173.73%	190,335 $1.8 Million
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $27,945 - $52,018	3,653 Added 5.54%	69,533 $706,000
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $207,382 - $330,983	-15,928 Reduced 19.47%	65,880 $939,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $396,288 - $523,059	20,480 Added 33.39%	81,808 $1.69 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $111,930 - $204,163	5,170 Added 9.21%	61,328 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $82,243 - $119,278	5,306 Added 10.43%	56,158 $1.17 Million
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $154,632 - $231,636	-10,420 Reduced 17.01%	50,852 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$9.4 - $16.7 $222,761 - $395,756	23,698 Added 63.07%	61,272 $927,000
Q3 2020 Nov 16, 2020	SELL	$10.54 - $24.96 $120,261 - $284,793	-11,410 Reduced 23.29%	37,574 $396,000
Q2 2020 Aug 14, 2020	SELL	$21.87 - $33.11 $371,527 - $562,472	-16,988 Reduced 25.75%	48,984 $1.2 Million
Q1 2020 May 15, 2020	BUY	$16.25 - $35.28 $1.07 Million - $2.33 Million	65,972 New	65,972 $1.59 Million

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $154M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Alector, Inc. Transaction History